Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in the discovery and development of human therapeutic drugs through the use of antisense technology. Founded in 1989 and headqua... Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in the discovery and development of human therapeutic drugs through the use of antisense technology. Founded in 1989 and headquartered in Carlsbad, California, Ionis is recognized for pioneering precision medicines that target RNA to modulate gene expression, addressing a variety of unmet medical needs. The company’s drug development pipeline spans several therapeutic areas, with a focus on severe and rare diseases, neurological disorders, and cardiovascular conditions. Notable for its significant investment in research and development, Ionis’s approach allows for the creation of novel therapies that might not be achievable through traditional pharmaceutical methods. In the broader financial market, Ionis Pharmaceuticals plays a key role within the health technology sector, representing innovative advancements in biotechnology and contributing to the progress of genomics-driven medicine. With a workforce of over 1,000 employees, Ionis continues to impact the healthcare landscape by advancing new treatment options for patients globally.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Climate Targets data disclosed by Ionis Pharmaceuticals

We reviewed Ionis Pharmaceuticals's website and available disclosure materials for the 2023 reporting period and did not identify any reported Climate Targets data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Ionis Pharmaceuticals's data?

Create a free Tracenable account to signal interest in having our team review data for Ionis Pharmaceuticals.

Legal Center Contact Us